Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials.
Smit JM, Van Der Zee PA, Stoof SCM, Van Genderen ME, Snijders D, Boersma WG, Confalonieri P, Salton F, Confalonieri M, Shih MC, Meduri GU, Dequin PF, Le Gouge A, Lloyd M, Karunajeewa H, Bartminski G, Fernández-Serrano S, Suárez-Cuartín G, van Klaveren D, Briel M, Schönenberger CM, Steyerberg EW, Gommers DAMPJ, Bax HI, Bos WJW, van de Garde EMW, Wittermans E, Grutters JC, Blum CA, Christ-Crain M, Torres A, Motos A, Reinders MJT, Van Bommel J, Krijthe JH, Endeman H.
Smit JM, et al. Among authors: snijders d.
Lancet Respir Med. 2025 Mar;13(3):221-233. doi: 10.1016/S2213-2600(24)00405-3. Epub 2025 Jan 29.
Lancet Respir Med. 2025.
PMID: 39892408